













1696Inhalation of methane preserves
the epithelial barrier during
ischemia and reperfusion in the
rat small intestine
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Background. Methane is part of the gaseous environment of the intestinal lumen. The purpose of this
study was to elucidate the bioactivity of exogenous methane on the intestinal barrier function in an
antigen-independent model of acute inflammation.
Methods. Anesthetized rats underwent sham operation or 45-min occlusion of the superior mesenteric
artery. A normoxic methane (2.2%)-air mixture was inhaled for 15 min at the end of ischemia and at
the beginning of a 60-min or 180-min reperfusion. The integrity of the epithelial barrier of the ileum was
assessed by determining the lumen-to-blood clearance of fluorescent dextran, while microvascular
permeability changes were detected by the Evans blue technique. Tissue levels of superoxide, nitrotyrosine,
myeloperoxidase, and endothelin-1 were measured, the superficial mucosal damage was visualized and
quantified, and the serosal microcirculation and mesenteric flow was recorded. Erythrocyte deformability
and aggregation were tested in vitro.
Results. Reperfusion significantly increased epithelial permeability, worsened macro- and microcirculation,
increased the production of proinflammatory mediators, and resulted in a rapid loss of the epithelium.
Exogenous normoxic methane inhalation maintained the superficial mucosal structure, decreased epithelial
permeability, and improved local microcirculation, with a decrease in reactive oxygen and nitrogen species
generation. Both the deformability and aggregation of erythrocytes improved with incubation of methane.
Conclusion. Normoxic methane decreases the signs of oxidative and nitrosative stress, improves tissue
microcirculation, and thus appears to modulate the ischemia-reperfusion–induced epithelial permeability
changes. These findings suggest that the administration of exogenous methane may be a useful
strategy for maintaining the integrity of the mucosa sustaining an oxido-reductive attack. (Surgery
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SURGERYreperfusion can cause injury in excess of that
induced by ischemia alone.1 It is commonly
accepted that re-established circulation is associ-
ated with the production of reactive oxygen and ni-
trogen species (ROS and RNS, respectively), which
leads subsequently to membrane breakdown and
loss of cellular integrity. In this way, events during
intestinal ischemia-reperfusion (IR) increase
quickly the mucosal permeability which leads to
excessive fluid losses and an influx of luminal
foreign material into the lamina propria.2
It is also recognized that the gastrointestinal
(GI) lumen contains a range of potentially bioac-
tive gas metabolites, such as carbon dioxide,3
hydrogen,4 ammonia,5 and hydrogen sulfide.6
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mosphere and is measurable in the exhaled breath
of approximately one-third of humans.7 The func-
tional consequences of CH4 production are subject
to debate; nevertheless, the formation of CH4 in
mammals is regarded as a specific indicator of car-
bohydrate fermentation by the anaerobe intestinal
flora. This latter route dependent on anaerobic
flora is probably not exclusive; various in vitro
and in vivo experiments have demonstrated alter-
native routes for the nonbacterial generation of
CH4 in conditions of oxido-reductive stress.
8,9
Although some data suggest a role in the
regulation of GI motility,10 the in vivo biologic ef-
fects of biotic or abiotic CH4 formation in the
gut are still not completely understood. A nor-
moxic CH4-air mixture decreases the biochemical
signs of inflammation after an IR challenge,11
and a number of other observations confirm the
anti-inflammatory properties of CH4, demon-
strated by decreases in levels of inflammatory cyto-
kine and markers of oxidative stress.12-16 In
addition, many published articles suggest that
CH4-based treatments have antiapoptotic effects
in model experiments.17-23
These converging research findings suggest that
CH4 can influence thepermeability status of themu-
cosa, a most critical factor in GI injuries in clinical
settings. Consequently, we devised experiments to
investigate the kinetics of CH4 distribution in the
blood and small intestine and the effects of exoge-
nous CH4 which leads to an approximately twofold
increase in the intraluminal CH4 concentration
over background levels; we evaluated these effects
on the epithelial and endothelial permeability and
secondary inflammatory reactions in a standardized
rat model of mesenteric IR.
Because the mucosal response may take the
form of either the rapid exacerbation of an injury
after the ischemic episode or of a slowly devel-
oping alteration,24 another goal of the study was to
characterize the consequences of normoxic CH4
inhalation separately in an early and a late period
of an IR-induced, antigen-independent inflamma-
tory challenge. Finally, additional in vitro model
experiments were performed to test the influence
of CH4 on erythrocyte membrane rigidity to inves-
tigate possible mechanisms of changes in the
microcirculation of the small intestine.
MATERIALS AND METHODS
The experiments were carried out on 76, male,
Sprague-Dawley rats (280–320 g body weight [bw])
in accordance with the National Institutes of Healthguidelineson thehandling andcareof experimental
animals and the EU Directive 2010/63 for the
protection of animals used for scientific purposes;
the study was approved by the National Scientific
Ethical Committee on Animal Experimentation
(National Competent Authority), with license num-
berV/148/2013. The animals werehoused inplastic
cages in a 12/12-h day/night cycle under standard
air temperature and humidity conditions. All chem-
icals were obtained from Sigma-Aldrich Inc (Buda-
pest, Hungary) unless stated otherwise.
Operative procedure. Rats fed on a normal
laboratory diet with tap water ad libitum were
allocated randomly into one or the other of the
experimental groups. After overnight fasting, the
animals were anesthetized with sodium pentobar-
bital (50 mg/kg bw intraperitoneal) and placed in
a supine position on a heating pad. The trachea
was dissected free and cannulated with a silicone
tube; then the right jugular vein was cannulated
with PE50 tubing for fluid administration and
Ringer’s lactate infusion (10 mL/kg/h) during
the experiments.
Experimental protocol. The experiments were
performed in 2 series (Fig 1). In study 1 (the “early
reperfusion” study), the animals were killed
60 min after the re-establishment of the mesenteric
blood flow; in the second set (the “late reperfusion”
study), the reperfusion period and the correspond-
ing control phase in the sham-operated animals
lasted for 180 min.
After a midline laparotomy, the superior mesen-
teric artery (SMA) was dissected free. Group 1
(n = 6) served as a sham-operated control, while in
Group 2 (IR, n = 6), the SMA was occluded using
an atraumatic vascular clip for 45 min. In the
CH4-treated Group 3 (IR + CH4, n = 6) an artificial
gas mixture containing 2.2% CH4, 21% O2, and
76.8% N2 (Linde Gas, Budapest, Hungary) was
administered for 5 min before the end of the
45-min ischemia and for 10 min at the beginning
of the reperfusion (Fig 1). In study 2, the protocol
followed was identical, but the durations of the
observation and the reperfusion phases were
different.
Epithelial permeability. Epithelial permeability
was determined with the 4 kDa fluorescein
isothiocyanate-dextran (FD4) method, as described
previously.25 In short, a 5-cm-long segment of the
terminal ileum supplied by 3 blood vessel arcades
was isolated at a distance of 10 cm from the ileocecal
valve. Silicone cannulas were placed and fixed into
the oral and aboral ends of the segment, and the
lumen was gently flushed with 5 mL of 378C
Fig 1. The experimental scheme. Rats were assigned randomly to 3 groups and each experimental group was divided




1698 Meszaros et al154 mM NaCl and 5 mL air; then the distal end was
closed.
Before performing measurements, the renal
pedicles were ligated. Exactly at the moment of
reperfusion (the “early reperfusion” study) or
120 min later (the “late reperfusion” study), the
lumen was filled with 0.5 mL of warmed (378C)
FD4 solution (25 mg/mL). Blood samples
(0.3 mL) were then taken 5, 10, 20, 30, and
40 min later for measurement of plasma fluores-
cein concentration with a fluorescence spectro-
photometer (F-2000; Hitachi, Tokyo, Japan, Ex:
492 nm; Em: 515 nm). The blood samples were
stored on ice in the dark and centrifuged at 100g
for 10 min. At the end of the experiment, the
bowel segment was removed and weighed. The
epithelial permeability index was expressed as a
percentage of FD4 measured in the plasma calcu-
lated using the formula (arterial FD4 concentra-
tion [ng/mL]/luminal FD4 concentration [ng/
mL] * 100).
Intestinal vascular permeability. The vascular
permeability index was determined using the azo
dye Evans blue method, as described previously.26
In brief, 30 min before the end of the experiments,
20 mg/mL/kg of Evans blue was given in intrave-
nous bolus and, at the end of the experiments, a
blood sample was taken from the caval vein
together with a whole-thickness tissue sample
from the ileum. The biopsy specimen was placed
in 5 mL of formamide and homogenized for
1 min in a glass Potter homogenizer. Thehomogenate was incubated at room temperature
for 20 h and then centrifuged at 2500g for 30 min.
The absorbance of the supernatant was deter-
mined at 650nmwith aUV-1601 spectrophotometer
(Shimadzu Corp, Kyoto, Japan) against a form-
amide blank. The concentration of Evans blue was
determined from a standard curve and was normal-
ized to the protein content of the samples.27 Simi-
larly, blood samples were centrifuged at 600g at
48C for 10 min, and the absorbance of the 100-fold
diluted plasma was measured. The vascular perme-
ability index was defined as the ratio of the tissue
and plasma concentrations of Evans blue: (tissue
Evans blue concentration/plasma Evans blue con-
centration) * 100.
SMA blood flow. The SMA flow signals (T206
Animal Research Flowmeter; Transonic Systems
Inc, Ithaca, NY) were measured continuously and
recorded with a computerized data acquisition
system (Experimetria Ltd, Budapest, Hungary).
Intravital videomicroscopy of the ileal microcir-
culation. A technique of intravital, orthogonal
polarization spectral imaging (Cytoscan A/R, Cy-
tometrics, Philadelphia, PA) was used for the
visualization of the serosal and mucosal micro-
circulation of the ileum. This technique uses
reflected polarized light at the wavelength of
the isosbestic point of oxyhemoglobin and
deoxyhemoglobin (548 nm). Because polarization
is preserved in reflection, only photons scattered
from a depth of 200 mm contribute to image
formation.
Surgery
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of the ileum, andmicroscopic images were recorded
with an S-VHS video recorder (Panasonic AG-TL
700, Matsushita Electric Ind Co Ltd, Osaka, Japan).
The quantitative assessment of the microcirculatory
parameters was performed off-line by a frame-to
frame blinded analysis of the videotaped images.
Changes in red blood cell (RBC) velocity (mm/s) in
the postcapillary venules were determined in 3
separate fields by means of a computer-assisted
image analysis system (IVM Pictron, Budapest,
Hungary). All microcirculatory evaluations were
performed by the same investigator (E. T.).
In vivo histology. The extent of superficial
epithelial damage of the terminal ileum was
evaluated by means of fluorescence confocal laser
scanning endomicroscopy (CLSEM) (Five1 Optis-
can Pty Ltd, Melbourne, Victoria, Australia) devel-
oped for in vivo histology. The mucosal surface of
the terminal ileum 10 cm proximal to the cecum
was exposed operatively and laid flat for examina-
tion. The injury of the mucosal architecture was
examined after topical application of the fluores-
cent dye acriflavin. The surplus dye was washed off
with 154 mM NaCl; then the objective of the device
was placed onto the mucosal surface of the ileum
and confocal imaging was performed 2 min after
dye administration (1 scan per image, 1024 3 1024
pixels and 475 3 475 mm per image).
Nonoverlapping fields were processed and eval-
uated by a modified semiquantitative scoring sys-
tem.28 The grading was performed using the 5
following criteria: Criterion I, denudation of villi
(0 = no denudation, 1 = at least one denuded
area per field of view, 2 = more than one area
without any recognizable villus structure per field
of view; Criterion II, edema (0 = no edema, 1 = mod-
erate epithelial swelling, 2 = severe edema);
Criterion III, shedding (0 = normal, clearly,
well-defined villus structure without shedding cells,
1 = some shedding cells; fewer than 30 cells per
field of view, 2 = shedding cells, more than 30 cells
per field of view, 3 = severe debris); Criterion IV,
epithelial gap (0 = no gap, 1 = less than 5 gaps
per villi, 2 = more than 5 gaps per villi); and Crite-
rion V, longitudinal fissure on villi (0 = no fissure,
1 = presence of fissure). A blinded analysis of the
same images was performed twice off-line (A.T.M.).
Preparation of ileum biopsies. Ileum biopsies
kept on ice were homogenized in a phosphate
buffer (pH 7.4) containing Tris-HCl (50 mM,
Reanal, Budapest, Hungary), EDTA (0.1 mM),
dithiotreitol (0.5 mM), phenylmethylsulfonyl
fluoride (1 mM), soybean trypsin inhibitor
(10 mg/mL), and leupeptin (10 mg/mL). Thehomogenate was centrifuged at 48C for 20 min at
24,000g (Amicon Centricon-100; Millipore Corpo-
ration, Bedford, MA). Tissue concentration of
nitrotyrosine (NTyr) was determined in the super-
natant, while myeloperoxidase (MPO) activity was
measured in the pellet of the homogenate.
Tissue MPO activity. The activity of MPO as a
marker of tissue leukocyte infiltration wasmeasured
in the pellet of the homogenate using the modified
method of Kuebler et al.29 In brief, the pellet was re-
suspended in a K3PO4 buffer (0.05 M; pH 6.0) con-
taining 0.5 % hexa-1,6-bis-decyltriethylammonium
bromide. After 3 repeated freeze-thaw procedures,
the material was centrifuged at 24,000g at 48C for
20min with the supernatant used for MPO determi-
nation. Afterward, 0.15 mL of 3,39,5,59-tetramethyl-
benzidine (dissolved in DMSO; 1.6 mM) and
0.75 mL of hydrogen peroxide (dissolved in
K3PO4 buffer; 0.6 mM) were added to 0.1 mL of
the sample. The reaction led to the hydrogen
peroxide–dependent oxidation of tetramethylben-
zidine, which was detected spectrophotometrically
at 450 nm (UV-1601 spectrophotometer; Shimadzu
Corp). MPO activities were measured at 378C; then
the reaction was stopped after 5min by the addition
of 0.2 mL of H2SO4 (2 M), and the resulting data
were normalized to the protein content.
Tissue levels of NTyr. Free NTyr as a marker of
peroxynitrite (ONOO) generation was measured
by an enzyme-linked, immunosorbent assay
(Cayman Chemical, Ann Arbor, MI). Small intesti-
nal tissue samples were homogenized and centri-
fuged at 24,000g. The supernatants were collected
and incubated overnight with anti-NTyr rabbit IgG
and an NTyr acetylcholinesterase tracer in pre-
coated (mouse anti-rabbit IgG) microplates, which
were developed using Ellman’s reagent. The NTyr
content was normalized to the protein content of
the small intestinal homogenate and expressed in
ng/mg.
Plasma endothelin-1 (ET-1) levels. Blood sam-
ples (0.5mL) were taken from the inferior caval vein
into chilled polypropylene tubes containing EDTA
(1mg/mL) in thefinal stageof the “late reperfusion”
experiments (180 min after reperfusion), centri-
fuged at 1,000g at 48C for 30 min, and then stored
at708C until assay. The plasma ET-1 concentration
was determined in duplicates bymeans of a commer-
cially available, enzyme-linked, immunosorbent assay
kit (Biochemica Hungaria Ltd, Budapest, Hungary)
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1700 Meszaros et aldescribed by Ferdinandy et al.30 In short, approxi-
mately 10 mg of intestinal tissue was placed in
1 mL of Dulbecco’s solution (pH 7.4) containing
5 mM of lucigenin. The manipulations were per-
formed without external light 2 min after dark
adaptation. Chemiluminescence was measured at
room temperature in a liquid scintillation counter
using a single active photomultiplier positioned in
out-of-coincidence mode in the presence or
absence of the O2
C scavenger nitroblue tetrazo-
lium (NBT; 20 ml). NBT-inhibited chemilumines-
cence was interpreted as an indicator of intestinal
O2
C generation.
Tissue and blood CH4 levels. The CH4 concen-
tration in tissue was measured by means of photoa-
coustic spectroscopy, as reported earlier.31 The
device had been calibrated previously with various
gas mixtures prepared by dilution of 1 vol% of CH4
in synthetic air; this device has a dynamic range of
4 orders of magnitude; the minimum online detect-
able concentration of the sensor was found to be
0.25 ppm (3s), with an integration time of 12 s.31
In a separate set of experiments, tissue CH4 con-
centration was measured multiple times in anes-
thetized rats after inhalation of room air or
artificial air containing 2.2% exogenous CH4. At
given timepoints (see Fig 2 for details), a 200 mg
ileum sample was taken, excess fluid was wiped
immediately off, and the tissue specimen was
placed in a glass vial with 20 mL headspace volume
and closed so as to be airtight. Parallel to taking
ileum biopsies, 1 mL of blood was taken from
the common carotid artery of the same animals
through a silicone cannula and was transferred
subsequently to identical glass vials. The outlet of
the vials was connected to the pump of the spectro-
scope and headspace gas was pumped into the
chamber of the device with a rate of 10 mL/min.
Photoacoustic spectroscopy is a special type of
spectroscopy that measures optical absorption
indirectly via the conversion of absorbed light
energy into acoustic waves. The amplitude of the
generated sound is directly proportional to the
concentration of the absorbing gas component.
The light source of the system is a near-infrared
diode laser that emits light around the absorption
line of CH4 at 1650.9 nm with an output power of
15 mW (NTT Electronics, Tokyo, Japan). The
cross-sensitivity for common components of breath
and ambient air were examined repeatedly, and no
measurable instrument response was found for
several vol% of CO2 or H2O vapor. The narrow
line width of the diode laser provides high selec-
tivity; the absorbance of CH4 is several orders of
magnitude greater than that of H2O, CO2, or COat 1.65 mm which was the wavelength we used.
The CH4 values were corrected for background
levels and expressed in parts per million (ppm).
In vitro microrheologic study. Study design, in-
duction of oxidative stress, and CH4 treatment. Venous
blood from healthy male volunteers was collected
in lithium heparin-coated tubes. Blood samples
were placed into 3 groups and incubated for
120 min at 378C on a roller bed before performing
measurements of RBC aggregation and deform-
ability. A nontreated sample served as the negative
control. Oxidative stress was induced with the
addition of phenazine methosulfate (PMS, dis-
solved in phosphate-buffered saline, final concen-
tration 200 mM) and incubation for 120 min.32
Before the study, a dose-response experiment
was performed with PMS concentrations between
0 and 400 mM to determine the effective concen-
tration. In the third, CH4-treated group, the head-
space of the sample was perfused continuously
with a gas mixture containing 2.2 % CH4 in nor-
moxic air (Messer Hungarogaz, Budapest,
Hungary) for 10 min after the end of the PMS in-
cubation protocol. RBC deformability and the ag-
gregation of samples were determined by means
of ektacytometry and light-transmission aggregom-
etry immediately after the incubation period. Sam-
ples here were taken from the same vials for both
measurements.
RBC deformability. RBC deformability in
response to shear forces was determined via a
LORCA ektacytometer (Laser-assisted Optical
Rotational Cell Analyzer; R&R Mechatronics,
Hoorn, The Netherlands). Immediately after the
treatment protocol, 20 mL of blood was suspended
in 4 mL of a polyvinylpyrrolidon solution, with a
viscosity of 29.8 mPas, and injected into the cylin-
der of the ektacytometer. During the measure-
ment, the temperature was kept at 378C.
Deformation is characterized by the elongation
index (EI) calculated from the diffraction pattern
of laser light on elongated RBCs. The light was
captured and analyzed by a video camera and a
computer system that calculated an EI as the
(length  width)/(length + width) of the pattern
for 9 different shear stress values ranging from
0.5 Pa to 50 Pa.33
RBC aggregation. The aggregation characteris-
tics of erythrocytes were assessed using a light
transmission method described previously.34
Immediately after the treatment protocol, 30 mL
of blood was transferred to a Myrenne MA-1
Aggregometer (Myrenne GmbH, Roetgen,
Germany). The blood sample was first sheared at
600 s1 to disperse all pre-existing aggregates,
Fig 2. CH4 concentrations in blood (A) and ileum (B)
samples taken during the CH4-air inhalation protocol
in a pilot study. Original recording of photoacoustic sig-
nals as a function of time. At the indicated time point
during the experiments, a tissue sample of the ileum,
weighing approximately 200 mg was taken and placed
immediately in a glass vial. Simultaneously, blood sam-
ples (1 mL each) were taken from the common carotid
artery into glass vials. Gas samples from the headspace
(20 mL) were transferred to the photoacoustic detection
system, and each tissue specimen was measured for
10 min. Values are expressed as parts per million
(ppm) and are corrected for background CH4 levels.
Baseline---prior to CH4 inhalation and ischemia. Isch
459 (CH4 59)---end of mesenteric ischemia, 5 min of nor-
moxic CH4 inhalation. Rep 10’ (CH4 159) ---tenth min of
reperfusion, end of the 15-min normoxic CH4
inhalation. Rep 609---60th min of reperfusion. Empty
vial---CH4 concentration without biological sample,
used for background correction.
Surgery
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rates. The extent of aggregation was characterized
by the aggregation index, calculated using the sur-
face area below the light intensity curve in a 10 s
period. Measurements were performed at ambient
room temperature.
Statistical analysis. GraphPad Prism 5.01 for
Windows (GraphPad Software, La Jolla, CA) was
used for a statistical evaluation of the data. The
statistical analysis was performed by a 2-way analysis
of variance of repeated measures followed by
Bonferroni post hoc test in normally distributed
data and a Kruskal-Wallis 1-way analysis of variance
on ranks combined with the Dunn method for
pairwise multiple comparisons in groups showing a
non-Gaussian distribution. Taking into account the
fact that parts of the in vivo data were not normally
distributed (not Gaussian), we displayed the data
as box plots where possible. Median values and the
interquartile ranges of the 75th and 25th percen-
tiles are given.
RESULTS
Inhaled CH4 is transported by the blood and the
gas accumulates in intestinal tissue. The CH4 con-
centration in the baseline samples of non-CH4-pro-
ducer animals remained below the background
levels in both the arterial blood and in the ileal tissue
prior to the beginning of the experiment (Fig 2, A
and B, “Baseline”). After 5 min of normoxic CH4
inhalation with a flow rate of 300 mL/min, at the
end of the SMA ischemia, substantially increased
concentrations of CH4were detected in the systemic
arterial blood and a slight increase in the ileum as
well (Fig 2, A and B, “Isch 459–CH4 59”). At 10 min
into the reperfusion phase, at the end of the
15 min inhalation of normoxic CH4-air mixture,
CH4 concentration in the ileal tissue also increased
(Fig 2, B, “Rep 109–CH4 159”). In samples taken at
the 60th min of the reperfusion, 50 min after the
end of CH4 treatment, no significant amounts of
CH4 were found in intestinal or blood samples
(Fig 2, A and B, “Rep 60”).
The small intestinal epithelial barrier function.
Epithelial permeability (EP) and vascular perme-
ability (VP) indices were determined simulta-
neously to assess the barrier function of the
intestinal mucosa during the re-establishment of
the blood flow to the previously ischemic tissues
(Fig 3, A). The EP did not change in sham-
operated control animals, while the plasma levels
of FD4 increased steeply in the IR group, indi-
cating a rapid deterioration of the epithelial bar-
rier function. Normoxic CH4 treatment resultedin significantly lesser EP levels, implying preserved
interepithelial junctions.
Later in the reperfusion phase (Fig 3, B), the EP
index in nontreated animals decreased, suggesting
an improved barrier function compared to that in
the early phase; while in the CH4-treated group,
the change was similar to that observed in the early
phase of reperfusion. The EP index remained at
the baseline level in the control animals.
Small intestinal microvascular barrier function.
No statistically significant changes in the VP
assessed by Evans blue extravasation were detected
Fig 3. Changes in epithelial permeability (EP) in the sham-operated (empty circles), mesenteric IR (black squares), and
CH4-treated IR (black triangles) groups during early (A) and late phases (B) of reperfusion. The EP was assessed in
each period, and the permeability index was calculated as described earlier (see the Methods section for a description
of the experiments). Data are expressed as median, 25th, and 75th percentiles. Here, * means P < .05; ** means P < .01
and *** means P < .001 between groups versus sham-operated group; ### means P < .001 between CH4-treated and IR
groups, while ++ means P < .01 and +++ P < .001 compared to baseline values within groups.
Fig 4. Changes in vascular permeability (VP) in the sham-operated (Sham, empty boxes), mesenteric IR (IR, checkered
boxes), and CH4-treated IR (IR+CH4, hatched boxes) groups during early (A) and late phases (B) of reperfusion. The
VP index was calculated using a spectrophotometric evaluation of Evans Blue extravasation (see Materials and
Methods section). The results are expressed as median, 25th, and 75th percentiles.
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(Fig 4, B) of reperfusion.
Macro- and microcirculatory changes. The SMA
blood flow was assessed continuously during the
experiments (Fig 5). In the IR and IR + CH4
groups, the complete cessation of blood flow was
followed by different reactions during reperfusion.
The SMA flow in the IR group remained signifi-
cantly low as compared to baseline levels, while
in CH4-treated animals, the SMA flow was signifi-
cantly greater compared to that in the IR group.
Prior to the induction of SMA occlusion, the
RBC velocity in the microvessels of the ileal serosa
was similar in all groups (Fig 6). In the 15th min of
reperfusion, the intestinal microcirculation of the
IR group was significantly impaired. In the
IR + CH4-treated groups, the RBC velocity did
not differ from that of the sham-operated groups,
implying improved microcirculation. By the120 min of the reperfusion, no differences were
seen among the groups.
Tissue ET-1 levels. The ET-1 concentration was
measured from plasma samples at the end of the
180-min reperfusion periods. In the IR group,
there was a significant increase in ET-1 concentra-
tion at 180 min after reperfusion relative to that in
the control animals. This increase was significantly
decreased in the IR + CH4-treated group (Fig 7, A).
Tissue MPO levels. The activity of MPO, a
marker enzyme of PMN granulocytes, was assessed
in intestinal homogenates at the end of the late
reperfusion phase. A significant MPO elevation
was present in both the IR and the CH4-treated
groups, indicating acute inflammation and extrav-
asation of leukocytes into the tissue (Fig 7, B).
ROS and RNS levels. Tissue NTyr concentration
(Fig 8, A) is an indicator of protein nitration pro-
duced by a chemical reaction associated with
Fig 5. Changes in the superior mesenteric artery (SMA)
blood flow in the sham-operated (empty circles), mesen-
teric IR (black squares), and CH4-treated IR (black trian-
gles) groups. 0 min on the X-axis denotes the start of
reperfusion. Results are expressed as median, 25th,
and 75th percentiles. Here, *** means P < .001 between
groups versus sham-operated group; # indicates P < .05
between CH4-treated and IR groups, while +++ means
P < .001 compared with baseline values within groups.
Fig 6. Changes in red blood cell (RBC) velocity in the
microvessels of the serosal surface of the ileum in
response to a sham operation (empty boxes) or 45 min
of mesenteric ischemia followed by 120 min of reperfu-
sion (IR groups, checkered boxes) and in rats treated with
a normoxic (21% O2) gas mixture containing 2.2%
CH4 for 5 min at the end of the ischemia and for
10 min at the beginning of the reperfusion period
(IR + CH4, hatched boxes). Measurements were performed
at baseline conditions (Baseline), 15 min after reperfu-
sion (Rep 159), and 120 min after reperfusion (Rep
1209). ** means P < .01 between groups versus sham-
operated group, ## means P < .01 between IR and
IR + CH4 groups, + means P < .05 compared with base-
line values within groups.
Surgery
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by the 180 min of reperfusion in the IR group as
compared to those in the sham-operated controls,
but the NTyr levels in the CH4-treated group did
not differ from the controls.
O2
Clevels. A primary cellular ROS, O2
C, was
detected in ileal biopsies at the beginning of exper-
iments (Fig 8, B), and no between-group differ-
ences were demonstrated. At 15 min after the re-
establishment of blood flow, the samples taken
from the IR group contained significantly greater
levels of O2
C than those from the control and
CH4-treated animals.
Structural integrity of small intestinal mucosa.
Intravital CLSEM images were recorded to obtain
information on the structural condition of the
mucosa, and these microscopic histology data were
evaluated using a semiquantitative scoring system
(Fig 9, D). Normal villi with intact epithelial cells
were observed in the control group (Fig 9, A).
When compared to the typically continuous, un-
broken epithelial lining in the sham-operated ani-
mals, after 30 min of reperfusion, the mucosa was
severely damaged with epithelial defects stretching
across the villi seen regularly in association with
increased luminal debris formation (Fig 9, B). No
epithelial disruptions on the lumen surface were
present in the CH4-treated group (Fig 9, C), and
the microstructural damage reflected in the injury
score was significantly less than that in nontreated
IR animals.
The effects of CH4 on the microhemorheologic
parameters of whole blood. The deformability oferythrocytes taken from human blood was
measured using a laser-assisted, optical rotational
method (Fig 10). Oxidative stress induced by
in vitro treatment with the oxidizer PMS resulted
in a significantly decreased elongation index
from low to moderately high shear stress rates
compared to that for the nontreated control sam-
ples. Normoxic CH4 incubation applied after the
oxidizer incubation was able to counteract in part
the decreased rigidity of RBCs at moderate levels
of shear stress (Fig 10, A–C). Moreover, oxidative
stress in vitro increased the aggregation of erythro-
cytes at low shear stress compared to that in con-
trol samples (Fig 11). After applying CH4, these
values significantly decreased to the level of non-
treated control samples.
DISCUSSION
Herein, we present new data on the biologic
effects of normoxic CH4 ventilation in a standard-
ized rat model of mesenteric IR. It is well recog-
nized that intestinal IR induces a range of
humoral and cellular reactions that have a com-
mon end point in transmucosal damage.35 The
potentially destructive pathways increase the
leakage of plasma into the interstitium and,
conversely, luminal substances can get into the
lymphatics and the bloodstream.
Fig 7. Changes in the plasma endothelin-1 (ET-1) concentration and tissue myeloperoxidase (MPO) activity at the end
of 180 min reperfusion in the sham-operated (Sham, empty box), IR (checkered box), and CH4-treated groups (IR + CH4,
hatched boxes). * means P < .05 between groups versus sham-operated group, # means P < .05 between IR and IR + CH4
groups.
Fig 8. Changes in mucosal nitrotyrosine (panel A) and superoxide (panel B) production in sham-operated control ani-
mals (Sham, empty boxes) and after 45 min of SMA occlusion and 180 min reperfusion (IR group, checkered boxes). In the
methane-treated group (IR + CH4, hatched boxes), the animals inhaled a normoxic (21% O2) gas mixture containing 2.2%
CH4 for 5 min at the end of the ischemia and for 10 min at the beginning of the reperfusion period (or 15 min in total).
The nitrotyrosine level was measured by means of enzyme-linked, immunosorbent assay from samples taken after 180 min
of reperfusion and normalized to the total protein content of the tissue. Superoxide levels (panel B) were measured by
chemiluminescence at the beginning of the experiment (Baseline) and at 15 min (Rep 159) and 120 min after reperfusion
(Rep 1209), and they were normalized to the protein content of the tissue sample. Data are expressed as median, 25th, and
75th percentiles. ** means P < .01 compared to sham-operated group; ## means P < .01 between the CH4-treated group
and IR group, while +++ means P < .001 compared to baseline values within groups.
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can range from moderate malfunction of the tight
junctions of the villus epithelium to manifest
discontinuity, the preservation or restoration of
the barrier is of vital importance in the salvage
therapies of several acute and chronic GI dis-
eases.36 Our study demonstrated that normoxic
CH4 inhalation influences effectively the epithelial
component of transmucosal permeability and the
early structural loss of the epithelial layer.
In the present study, the early and later conse-
quences of IR were characterized by biochemical,
macro- and microcirculatory, and morphologic
parameters. The IR-induced structural damage
was confirmed by in vivo endomicroscopy, and
direct intravital data were also obtained for thederangement of the intestinal microcirculation.
The impairment of nutritive perfusion and attach-
ment of circulating PMN leukocytes to the endo-
thelial wall are key events in the development of IR
injuries. The capillary no-reflow phenomenon37
and the spatial microcirculatory heterogeneity
can result in sustained local hypoxia. Conse-
quently, soluble inflammatory mediators are
released and, among others, ROS and RNS are
produced. ET-1, the most potent vasoconstrictor,
also contributes to PMN adhesion in submucosal
postcapillary venules and to the detrimental micro-
vascular consequences of mesenteric ischemia.38
These components of the IR pathology all lead to
the breakdown of membrane fences and to a crit-
ical second-wave inflammatory response.39
Fig 9. Top panel: in vivo histologic images recorded by confocal laser scanning endomicroscopy (CLSEM) after the
topical administration of sodium acriflavine. (A) The normal structure of the mucosa in the control group. (B) Loss
of epithelium with disruptions on the villus surface after 45 min SMA occlusion and 30 min reperfusion. (C) Nearly
intact villus surface after the inhalation of a normoxic (21% O2) gas mixture containing 2.2% CH4 for 5 min at the
end of ischemia and for 10 min at the beginning of the reperfusion period. Bottom panel (D): grading of in vivo
histology on a semiquantitative scoring system. The plots show the median and the 25th and 75th percentiles. Here,
* means P < .05 between groups versus sham-operated group, # means P < .05 between the IR and IR + CH4 group.
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CH4 can protect the tissues from the development
of these anti-inflammatory activities. It has been
shown repeatedly by various research groups that
experimental CH4 treatment counteracts inflam-
matory cytokine production and stimulates antiox-
idative defense systems.12-16 In the current
experiments, the decrease in epithelial perme-
ability after CH4 inhalation was associated with
decreased generation of ROS and RNS and
decreased ET-1 levels.
CH4 treatment improved both serosal microcir-
culation and SMA flow which, in turn, delivers
more oxygen to the cells and allows effective oxida-
tive phosphorylation by mitochondria. The
normalized ET-1 plasma levels in the CH4-treatedgroups can reflect the improved local microcircu-
latory state on the one hand, and the decrease in
inflammatory activation on the other. This observa-
tion accords with an earlier finding that CH4 treat-
ment decreases xanthine oxidoreductase activity11;
being the most important ROS-producing enzyme
in the postischemic gut,40 the inhibition of
xanthine oxidoreductase contributes to the
decrease in O2C
 production in the postischemic
intestinal tissue.
In our study, we used FITC-labeled dextrane with
a molecular weight of 4 kDa, a good indicator of the
paracellular epithelial permeability pathway41
mediated predominantly by tight junctions. The
influence of an increased intraluminal CH4 concen-
tration on the epithelial permeability is of interest,
Fig 10. Changes in deformability of RBCs in vitro under increasing shear stress rates at 1.57 Pa (A), 2.81 Pa (B), and
5.00 Pa (C) depicted as box plots. The greater elongation indices represent more elongated, hence more oval, eryth-
rocytes. Control samples (empty boxes), samples incubated with PMS for 2 h to induce oxidative stress (PMS groups, check-
ered boxes), and blood samples treated with a normoxic (21% O2) gas mixture containing 2.2% CH4 for 10 min after 2 h
of PMS challenge (PMS + CH4, hatched boxes). The box plots show the median and the 25th and 75th percentiles. Here,
*P < .05 and **P < .01 PMS versus control group and n = 4–5.
Fig 11. RBC aggregation in vitro. The light transmission
of rapidly aggregating samples at low shear rates was
measured for 10 s, and the aggregation index was calcu-
lated. Control samples (empty boxes), samples incubated
with PMS for 2 h to induce oxidative stress (PMS group,
checkered boxes), and blood samples treated with a nor-
moxic (21% O2) gas mixture containing 2.2% CH4 for
10 min after 2 h of PMS challenge (PMS + CH4, hatched
boxes). The plots show the median and the 25th and 75th
percentiles. Here, * means P < .05 PMS versus control
group and n = 4–5.
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taining the intestinal barrier in many clinical
settings.42 In theory, CH4 can protect tight junctions
from opening by directly influencing membrane
fluidity or by preserving the ATP levels of epithelial
cells. The maintenance of intercellular tight junc-
tions among mucosal epithelial cells is an energy-
dependent mechanism.43 The improved micro-
and macrocirculation of the postischemic gut after
CH4 treatment was demonstrated in the present
study; hence, increased oxidative phosphorylation
early in the reperfusionmay allow the cells to return
to sufficient energy levels that maintain tight junc-
tion proteins in the tightly closed conformation.Because no specific receptors or other signal-
ling molecules of CH4 have been reported to date,
we hypothesized that CH4 can modulate plasma
membrane fluidity by being dissolved in the apolar
lipid phase. The tissue NTyr level is an indicator of
protein nitration, associated with increased levels
of peroxynitrite, which is a potent initiator of
membrane lipid peroxidation44; it was reported
earlier that IR-associated lipid peroxidation de-
creases membrane fluidity in various tissues45 and
in erythrocytes as well.46 The membrane and cyto-
skeleton are responsible together for altering the
shape of the erythrocyte.47 Lipid peroxidation
breaks the connection between the 2 compo-
nents,48 and consequently, both the deformability
and aggregation of the RBCs is influenced in a
detrimental way.49 Brath et al50 reported worsened
RBC deformability and increased aggregation in
the early reperfusion after experimental mesen-
teric ischemia in the rat portal vein. Because
normal erythrocytes are approximately 25%
greater in diameter than the mean diameter of
capillaries, sufficient RBC deformability is a pre-
requisite in normal capillary blood flow.51,52
With this in mind, an in vitro microrheologic
study with human whole blood was designed
without the confounding in vivo effects of vasoac-
tive metabolites. We showed that an oxidative
challenge significantly decreased the elongation
index of RBCs. With normoxic CH4 treatment, the
RBC deformability improved at low to moderate
shear stress rates, suggesting a direct effect of
CH4 on membrane fluidity and/or membrane-
cytoskeleton junctions. Aggregation was measured
in the same experimental setting at low rates of
shear stress. Once again, the increased aggregation
index of RBCs provided evidence for the role of
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alleviated this response.
Thus, these data provide evidence for the direct,
beneficial effects of CH4 exerted in the oxidized
biomembranes of erythrocytes. The improvement
in microcirculation with CH4 treatment is probably
the net result of a complex mechanism, with
decreased production of O2C
 and less membrane
damage (indicated by lesser levels of malondialde-
hyde, reported previously21) while, at the same
time, accumulation of CH4 in the lipid phase
further increases RBC deformability.
The effects of CH4 on the IR-induced changes
in vascular permeability are less clear, because
in this model, the epithelial and endothelial
permeability-specific changes were affected differ-
entially by the IR cycle. Epithelial permeability
significantly deteriorated immediately after reper-
fusion, while the extravasation of the circulating
endothelial tracer did not increase to a great
extent. Therefore, the relative effect of CH4
administration on microvascular permeability
could not be evaluated simultaneously. We assume
that CH4 diffused from the circulating blood
through the endothelial layer, a step which should
lead to a continuous CH4 supply to the endothelial
cell membranes as well; however, we cannot
exclude a possible interference of the techniques
(ie, FITC-labeled dextrane and Evans blue mea-
surements). The measurements of epithelial and
endothelial permeability were conducted simulta-
neously in the same animal for ethical reasons,
and this approach could influence the sensitivity
of these methods. Therefore, future studies are
needed to examine the influence of CH4 on micro-
vascular permeability directly and independent of
other factors.
An assessment of the kinetics of the inhaled
CH4 revealed that in our inhalation regimen, sig-
nificant amounts of CH4 are already in the sys-
temic circulation at the end of reperfusion,
allowing rapid equilibration with the intestinal tis-
sue early in the reperfusion, as confirmed by pho-
toacoustic spectroscopy measurements. By the
60th min of reperfusion, CH4 levels fell to the
baseline levels.
The effects of CH4 inhalation were studied for
60minand180minafter the restorationof themesen-
teric blood flow. The epithelial barrier of the ileum
was already restored in part in the later phase of the
reperfusion, as indicated by the lesser FD4 clearances,
both in the IR and IR + CH4-treated groups. The
normalizing signs seen after the transient ischemic
challenge support our assumption that the intestinal
metabolism was returning to normal.The difference between the intensities of early
and later changes in epithelial permeability, how-
ever, suggest that on the re-establishment of the
blood and oxygen supply, the endogenous de-
fense mechanisms cannot immediately control or
counteract the damaging reactions. Salvage thera-
pies should target this initial step to avoid long-
term or distant consequences of the barrier dam-
age, and CH4 treatment met this need. Although
even a brief 15-min CH4 inhalation preserved the
function of the postischemic gut sufficiently,
continuous, long-term CH4 supplementation
might have additional beneficial effects.
In conclusion, our results revealed that IR
leads to significant increases in epithelial perme-
ability, and CH4 is able to counteract these detri-
mental effects at this early and decisive phase of
the loss of mucosal integrity; however, it is still
not known whether the findings in this experi-
mental model are applicable in other conditions.
It remains to be determined what role the trans-
membrane proteins of the epithelial tight junc-
tions play into this effect and through what
steps CH4 is able to modulate the intercellular
connections.
We demonstrated that CH4 improves directly
the deformability and aggregation of erythrocytes
on oxidative stress. Moreover, we provide here
the first detailed measurements of the distribution
kinetics of inhaled CH4 in an animal model of
mesenteric IR. One limitation of the study, howev-
er, is that we did not assess directly the conforma-
tional changes of tight junction proteins, which
was beyond the scope of the present study. To
address these issues, further investigations are
needed, but the data presented here establish
clearly a mucosa-protective, antipermeability role
for exogenous CH4 administration.
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